TTM
$62.8B
YoY change
+8.6%
5Y CAGR
+6.0%
Peak year (FY2025)
$61.2B
Cumulative revenue
$594B
Revenue history chart for AbbVie (ABBV) from 2016 to 2025
Latest: $61.2B
Revenue growth chart for AbbVie (ABBV) from 2016 to 2025
Latest: +8.6%
Revenue history table for AbbVie (ABBV) from 2009 to 2025
| FY2025 | $61.2B | +8.6% | +$4.83B | ||
| FY2024 | $56.3B | +3.7% | +$2.02B | ||
| FY2023 | $54.3B | -6.4% | -$3.74B | ||
| FY2022 | $58.1B | +3.3% | +$1.86B | ||
| FY2021 | $56.2B | +22.7% | +$10.4B | ||
| FY2020 | $45.8B | +37.7% | +$12.5B | ||
| FY2019 | $33.3B | +1.6% | +$513M | ||
| FY2018 | $32.8B | +16.1% | +$4.54B | ||
| FY2017 | $28.2B | +10.1% | +$2.58B | ||
| FY2016 | $25.6B | +12.2% | +$2.78B | ||
| FY2015 | $22.9B | +14.5% | +$2.9B | ||
| FY2014 | $20B | +6.2% | +$1.17B | ||
| FY2013 | $18.8B | +2.2% | +$410M | ||
| FY2012 | $18.4B | +5.4% | +$936M | ||
| FY2011 | $17.4B | +11.5% | +$1.81B | ||
| FY2010 | $15.6B | +10.0% | +$1.42B | ||
| FY2009 | $14.2B | — | — |
- FY2025$61.2B+8.6%
- FY2024$56.3B+3.7%
- FY2023$54.3B-6.4%
- FY2022$58.1B+3.3%
- FY2021$56.2B+22.7%
- FY2020$45.8B+37.7%
- FY2019$33.3B+1.6%
- FY2018$32.8B+16.1%
- FY2017$28.2B+10.1%
- FY2016$25.6B+12.2%
- FY2015$22.9B+14.5%
- FY2014$20B+6.2%
- FY2013$18.8B+2.2%
- FY2012$18.4B+5.4%
- FY2011$17.4B+11.5%
- FY2010$15.6B+10.0%
- FY2009$14.2B—
Revenue values are taken from AbbVie's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Revenue at AbbVie (ABBV)
According to AbbVie's latest reported financial statements, the company's current revenue (TTM) is $62.8B. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, AbbVie (ABBV) reported revenue of $61.2B – grew 8.6% year-over-year.
AbbVie revenue has grown for 2 consecutive years, with a +6.0% compound annual growth rate over 2020–2025 (5 years).
Across the available history, revenue reached its high of $61.2B in 2025 and its low of $14.2B in 2009.
AbbVie Revenue by Year
AbbVie Revenue 2025: $61.2B
AbbVie revenue in 2025 was $61.2B, grew 8.6% from 2024. This figure represents the highest annual value in the available history.
AbbVie Revenue 2024: $56.3B
2024's revenue for AbbVie came in at $56.3B, edged up 3.7% from 2023.
AbbVie Revenue 2023: $54.3B
AbbVie posted revenue of $54.3B in 2023, declined 6.4% below 2022.
AbbVie Revenue 2022: $58.1B
In 2022, AbbVie reported revenue of $58.1B, edged up 3.3% from 2021.
AbbVie Revenue 2021: $56.2B
AbbVie revenue in 2021 was $56.2B.
See more financial history for AbbVie (ABBV).
Sector peers by Revenue
Healthcare peers of AbbVie (ABBV), ranked by their latest revenue
| $448B | |
| $94.2B | |
| $65.2B | |
| $64.9B | |
| $48.2B | |
| $44.6B | |
| $44.3B | |
| $36.7B |
- $94.2B
- $65.2B
- $64.9B
- $48.2B
- $36.7B
Frequently asked questions
AbbVie (ABBV) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.